Accessibility Menu
Abingdon Health Plc logo

Abingdon Health Plc(LSE) ABDX

Market Cap£45.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)-90%
5 Year-66%
1 Year+61%
1 Month+3%
£0.10
+0.40%
+0.00Today
Abingdon Health Plc last closing stock price
MetricPriceDate
Last closeGBX 10.042026-08-13
Abingdon Health Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-4.38%GBX 10.502026-08-06
1 month+2.97%GBX 9.752026-07-14
3 month-12.7%GBX 11.502026-05-15
Year to date+56.87%GBX 6.402025-12-31
1 year+60.64%GBX 6.252025-08-13
3 year+14.74%GBX 8.752023-08-14
5 year-66.15%GBX 29.662021-08-13
Since inception-90.02%GBX 1.052020-12-15

Abingdon Health Plc Financials at a Glance

Market Cap

£45.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

£16.39M

Net Income (TTM)

-£5.83M

EPS (TTM)

-£0.01

P/E Ratio

-12.65

Dividend

£0.00

Beta (Volatility)

0.12 (Low)

Price

£0.10

Volume

23,909

Open

£0.11

Previous Close

£0.10

Daily Range

£0.10 - £0.11

52-Week Range

£0.05 - £0.13

Estimated Earnings Date

Nov 18, 2026

ABDX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Abingdon Health Plc

Abingdon Health Plc is a UK-based company specializing in the development and distribution of diagnostic instruments. Established in 2008, the company focuses on innovative solutions for rapid testing, particularly in the healthcare sector.

Products and Services
  • AbC-19 Rapid Test for COVID-19 IgG antibodies
  • Seralite for measuring immunoglobulin free light chains in blood serum
  • AppDx technology for smartphone-based lateral flow reading
Growth Outlook
  • Recent quarterly revenue reached £4.24 million, indicating strong market demand
  • Partnerships with health tech firms enhance product offerings and market reach
  • Focus on expanding diagnostic solutions positions the company for future growth
Financial Highlights
  • Trailing twelve months revenue of £18.5 million reflects a solid performance
  • Current ratio of 1.91 indicates strong liquidity and financial health
  • Net income for the latest quarter was -£2.35 million, showing ongoing investment in growth
Abingdon Health Plc operates in the medical diagnostics and research industry, providing essential tools for healthcare professionals. The company's innovative products, such as the AbC-19 Rapid Test and Seralite, cater to the growing demand for rapid and accurate diagnostic solutions. With a focus on strategic partnerships and expanding its product line, Abingdon Health is well-positioned to capitalize on emerging opportunities in the healthcare sector. Recent financial data indicates a commitment to growth, despite current challenges reflected in net income figures. The company's strong liquidity and market presence suggest potential for future success in the evolving diagnostics landscape.
AI Generated • Jul 26, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

CEO

Chris Henry Francis Yates

Website

www.abingdonhealth.com

Headquarters

York, YK YO41 1LZ, GB

ABDX Financials

Key Financial Metrics (TTM)

Gross Margin

34.11%

Operating Margin

-45.70%

Net Income Margin

-33.88%

Return on Equity

-55.91%

Return on Capital

-63.61%

Return on Assets

-30.73%

Earnings Yield

-7.91%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

£45.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

435.07M

Volume

23.91K

Avg. Volume

166.82K

Financials (TTM)

Gross Profit

£6.44M

Operating Income

-£6.85M

EBITDA

-£5.04M

Operating Cash Flow

-£4.85M

Capital Expenditure

-£369.00K

Free Cash Flow

-£5.22M

Cash & ST Invst.

£3.71M

Total Debt

£948.00K

Abingdon Health Plc Performance Analysis

Abingdon Health Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30GBP 2,835,000N/A
20232023-06-30GBP 4,045,00042.7%
20242024-06-30GBP 6,135,00051.7%
20252025-06-30GBP 8,429,00037.4%
Abingdon Health Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-3054.6%
Q22024-12-31-16.9%
Q42025-06-3072.4%
Q22025-12-31-20.6%
Abingdon Health Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30GBP -0.07N/A
20232023-06-30GBP -0.01-84.4%
20242024-06-30GBP -0.00-63.2%
20252025-06-30GBP -0.01121.4%
Abingdon Health Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-3094.9%
Q22024-12-31-3450.0%
Q42025-06-3066.2%
Q22025-12-31-150.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

£4.24M

+75.8%

Gross Profit

£1.05M

-17.5%

Gross Margin

24.88%

N/A

Market Cap

£45.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

£404.27K

N/A

Employees

113

N/A

Net Income

-£2.35M

-94.9%

EBITDA

-£2.50M

-177.6%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

£3.71M

+85.5%

Total Debt

£948.00K

-6.0%

Accounts Receivable

£2.35M

+135.5%

Inventory

£638.00K

+55.2%

Long Term Debt

£658.00K

-27.8%

Short Term Debt

£290.00K

+49.5%

Return on Assets

-30.73%

N/A

Return on Invested Capital

-62.02%

N/A

Free Cash Flow

-£1.31M

-7.5%

Operating Cash Flow

-£1.28M

-7.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PXS.LProvexis plc
£0.01-10.31%
GDR.LGenedrive Plc
£0.01-2.62%
COG.LCambridge Cognition Holdings Plc
£0.32-3.03%
IXI.LIXICO plc
£0.08+1.33%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$9.77+0.00%
NOKNokia
$10.32+0.09%
SPCXSpace Exploration Technologies
$146.15+0.10%
SMCISuper Micro Computer
$37.61+0.19%

Questions About ABDX

What is the current price of Abingdon Health Plc?

Abingdon Health Plc is trading at £0.10 per share.

What is the 52-week range for Abingdon Health Plc?

Over the past 52 weeks, Abingdon Health Plc has traded between £0.05 and £0.13.

How much debt does Abingdon Health Plc have?

As of the most recent reporting period, Abingdon Health Plc reported total debt of £1.03M.

How much cash does Abingdon Health Plc have on hand?

Abingdon Health Plc reported £1.92M in cash and cash equivalents in its most recent financial results.

What is Abingdon Health Plc’s dividend yield?

Abingdon Health Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services